Back to User profile » Dr Chih-Yen Tu
Papers published by Dr Chih-Yen Tu:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
Chen CH, Tu CY, Chen WC, Kuo LK, Wang YT, Fu PK, Ku SC, Fang WF, Chen CM, Lai CC
Infection and Drug Resistance 2021, 14:2251-2258
Published Date: 16 June 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
Huang WC, Chen CY, Liao WC, Wu BR, Chen WC, Tu CY, Chen CH, Cheng WC
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1555-1568
Published Date: 3 June 2021
The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
Cheng WC, Hsia TC, Tu CY, Chen HJ
OncoTargets and Therapy 2020, 13:13425-13435
Published Date: 5 January 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment
Cheng WC, Wu BR, Liao WC, Chen CY, Chen WC, Hsia TC, Tu CY, Chen CH, Hsu WH
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3375-3384
Published Date: 22 December 2020